Pharmafile Logo

real-time data

- PMLiVE

New NHS treatments increase survival rates for babies with spinal muscular atrophy

Around 70 babies are born with the rare muscle-wasting disease each year in the UK

- PMLiVE

UK government unveils vaccine development hub to strengthen pandemic defences

The centre will support the development of vaccines against new threats

- PMLiVE

Creating truly effective communications – the impact of high speed, high octane messaging

Navigating the busy omnichannel communication lanes to make the best of digital

- PMLiVE

Eli Lilly announces positive results for Retevmo in phase 3 lung cancer study

Non-small cell lung cancer accounts for up to 85% of all lung cancer cases in the US

dengue fever mosquito

Bavarian Nordic’s chikungunya vaccine candidate shows promise in late-stage trial

There is currently no approved vaccine or specific treatment for chikungunya virus infections

- PMLiVE

Innovate UK awards Sano Genetics £330,000 grant for ALS study

The project will chart the psychological impacts of having a genetic predisposition to ALS

- PMLiVE

GSK discovers strain of bacterium that stops malaria transmission

It is hoped that the discovery could contribute to the eradication of the disease

- PMLiVE

Research Partnership announces two new senior leadership hires

Sue Wild will be joining as president, US pharma and Tom Donnelly as a director in the US MedTech division

- PMLiVE

AstraZeneca/Sanofi’s RSV antibody backed by CDC advisory committee for infants

Beyfortus will be available in the US ahead of the upcoming RSV season

- PMLiVE

GSK files lawsuit against Pfizer over RSV vaccine patent infringement

The RSV vaccine market is estimated to exceed $5bn and could surpass $10bn by 2030

- PMLiVE

AI-supported mammography screening shows promise in breast cancer detection

The AI-supported screening tool detected cancer in 244 people in the study

- PMLiVE

Porterhouse Insights appoints Ann-Marie Mulhall as account director

Mulhall brings seven years of healthcare research agency experience to the role

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links